1. Wang, W.Y., Chen, L.H., Ma, W.J., and You, R.X. (2023). Drug efficacy and safety of denosumab, teriparatide, zoledronic acid, and ibandronic acid for the treatment of postmenopausal osteoporosis: a network meta-analysis of randomized controlled trials. Eur Rev Med Pharmacol Sci 27, 8253-8268. 10.26355/eurrev_202309_33586.
2. Lund, T., Gundesen, M.T., Juul Vangsted, A., Helleberg, C., Haukås, E., Silkjær, T., Asmussen, J.T., Manuela Teodorescu, E., Amdi Jensen, B., Schmidt Slørdahl, T., et al. (2024). In multiple myeloma, monthly treatment with zoledronic acid beyond two years offers sustained protection against progressive bone disease. Blood Cancer J 14, 65. 10.1038/s41408-024-01046-2.
3. Annamalai, S., Kamalakaran, A., Jayaraman, B., Selvakumar, A., and Kulkarni, H.S. (2025). Multidisciplinary approach for medication-related osteonecrosis of the jaws: a case report and literature review. Arch Craniofac Surg 26, 70-75. 10.7181/acfs.2024.0091.
4. Martins, L.H.I., Ferreira, D.C., Silva, M.T., Motta, R.H.L., Franquez, R.T., and Bergamaschi, C.C. (2023). Frequency of osteonecrosis in bisphosphonate users submitted to dental procedures: A systematic review. Oral Dis 29, 75-99. 10.1111/odi.14003.
5. Topkan, E., Kucuk, A., Somay, E., Yilmaz, B., Pehlivan, B., and Selek, U. (2023). Review of Osteoradionecrosis of the Jaw: Radiotherapy Modality, Technique, and Dose as Risk Factors. J Clin Med 12. 10.3390/jcm12083025.
6. Jelin-Uhlig, S., Weigel, M., Ott, B., Imirzalioglu, C., Howaldt, H.P., Böttger, S., and Hain, T. (2024). Bisphosphonate-Related Osteonecrosis of the Jaw and Oral Microbiome: Clinical Risk Factors, Pathophysiology and Treatment Options. Int J Mol Sci 25. 10.3390/ijms25158053.
7. Filho, A.M., Laversanne, M., Ferlay, J., Colombet, M., Piñeros, M., Znaor, A., Parkin, D.M., Soerjomataram, I., and Bray, F. (2025). The GLOBOCAN 2022 cancer estimates: Data sources, methods, and a snapshot of the cancer burden worldwide. Int J Cancer 156, 1336-1346. 10.1002/ijc.35278.
8. Rogers, S.N., D'Souza, J.J., Lowe, D., and Kanatas, A. (2015). Longitudinal evaluation of health-related quality of life after osteoradionecrosis of the mandible. Br J Oral Maxillofac Surg 53, 854-857. 10.1016/j.bjoms.2015.07.008.
9. de Almeida-Silva, L.A., Lupp, J.D.S., Sobral-Silva, L.A., Dos Santos, L.A.R., Marques, T.O., da Silva, D.B.R., Caneppele, T.M.F., and Bianchi-de-Moraes, M. (2024). The incidence of osteoradionecrosis of the jaws in oral cavity cancer patients treated with intensity-modulated radiotherapy: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol 138, 66-78. 10.1016/j.oooo.2024.04.008.